Invesco Biotechnology & Genome ETF
PBE
PBE
88 hedge funds and large institutions have $64.3M invested in Invesco Biotechnology & Genome ETF in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
Holders
88
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$593K | |
| 2 | +$406K | |
| 3 | +$345K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$240K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$234K |
Top Sellers
| 1 | -$728K | |
| 2 | -$206K | |
| 3 | -$157K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$129K |
| 5 |
COF
Capital One Financial
Mclean,
Virginia
|
-$110K |